# Robert Routley

> Robert Routley is a Series B investor at Acorn Capital backing Software and Electronics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Acorn Capital](https://shizune.co/investors/profile/acorn-capital)
- Total investments: 4
- Last investment: Jun 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/robert-routley-702569163/details/experience

Robert Routley is a Series B investor at Acorn Capital focused on Software and Electronics. Robert Routley

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 25% |
| Electronics | 1 | 25% |
| Health Care | 1 | 25% |
| Manufacturing | 1 | 25% |
| Health Diagnostics | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Series A | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Australia | 1 | 25% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Liquid Instruments | Liquid Instruments develops software-defined test and measurement systems that enable engineers and scientists to perform complex experiments and signal analysis using a single, reconfigurable hardware platform. The company’s core offering is the Moku product line, which integrates multiple laboratory instruments, such as oscilloscopes, spectrumanalyzers, waveform generators, and lock-in amplifiers, into one device that can be configured and updated through software. Its platform is built on field-programmable gate arrays, allowing users to dynamically switch between instrument functions or combine multiple tools within the same system depending on testing requirements. This approach replaces traditional setups that rely on multiple standalone instruments, reducing equipment complexity, cost, and physical space while enabling customized configurations for different applications. | $8M | Venture - Series Unknown | Jun 19, 2024 |  |
| ImmVirX | ImmVirX hopes to advance a new generation of cancer treatments,By developing a novel oncolytic immunotherapy that targets cancer indications with high unmet need | $25M | Series B | Jun 05, 2023 |  |
| Liquid Instruments | Liquid Instruments develops software-defined test and measurement systems that enable engineers and scientists to perform complex experiments and signal analysis using a single, reconfigurable hardware platform. The company’s core offering is the Moku product line, which integrates multiple laboratory instruments, such as oscilloscopes, spectrumanalyzers, waveform generators, and lock-in amplifiers, into one device that can be configured and updated through software. Its platform is built on field-programmable gate arrays, allowing users to dynamically switch between instrument functions or combine multiple tools within the same system depending on testing requirements. This approach replaces traditional setups that rely on multiple standalone instruments, reducing equipment complexity, cost, and physical space while enabling customized configurations for different applications. | $28.5M | Series B | Sep 13, 2022 |  |
| ImmVirX | ImmVirX hopes to advance a new generation of cancer treatments,By developing a novel oncolytic immunotherapy that targets cancer indications with high unmet need | $22M | Series A | May 14, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Lockheed Martin Ventures](https://shizune.co/investors/profile/lockheed-martin-ventures) — VC Fund, 2 deals together
- [ANU Connect Ventures](https://shizune.co/investors/profile/anu-connect-ventures) — VC Fund, 1 deal together
- [Boman Enterprises](https://shizune.co/investors/profile/boman-enterprises) — VC Fund, 1 deal together
- [Breakthrough Victoria](https://shizune.co/investors/profile/breakthrough-victoria) — VC Fund, 1 deal together
- [Changer Club](https://shizune.co/investors/profile/changer-club) — VC Fund, 1 deal together
- [Decacorn Capital](https://shizune.co/investors/profile/decacorn-capital) — VC Fund, 1 deal together

## About Acorn Capital

VC Fund · Melbourne, Australia

Acorn Capital is a boutique investment manager that manages active VC and micro funds. It defines the public or listed microcap sector as those listed public companies that have market capitalizations less than the 250th largest company on the ASX. Acorn Capital’s research-driven investment process has been designed to take advantage ofinefficiencies that can exist in the microcap sector arising from poor information flows and the lack of liquidity. In contrast to the largest companies listed on the ASX, where there is a wealth of research and information, there is a relative lack of information on microcaps.

2 contacts available at Acorn Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Ben Dalling | Investment Director | https://shizune.co/investors/profile/ben-dalling |
| Robert Routley | Chief Executive Officer | https://shizune.co/investors/profile/robert-routley-cc5e |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Robert Routley invest in?

Robert Routley invests primarily in Software, Electronics and Health Care startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Robert Routley last invest?

The most recent investment recorded for Robert Routley closed in Jun 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co